“A 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild COVID-19.”
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and...
pubmed.ncbi.nlm.nih.gov
Since Pub Med has a wide audience of doctors, nurses, and consumers within the states, likely more doctors are prescribing it more than ever before for other off-label uses.